| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |